región of gene X, which determines the length of the tail in mice, is mutated so the that transcription factors bind it at a much higher affinity compared to the wild-type sequence. What is the most likely phenotypic outcome? Tail length will not change because the enhancer is a non-coding sequence Tail length will increased due to increased activity of the gene's promoter Tail length will decreased because any mutation will cause a loss-of-function of these regulatory regions Not just the tail will be enlarged because increased activity of the enhancer will impact many genes

región of gene X, which determines the length of the tail in mice, is mutated so the that transcription factors bind it at a much higher affinity compared to the wild-type sequence. What is the most likely phenotypic outcome? Tail length will not change because the enhancer is a non-coding sequence Tail length will increased due to increased activity of the gene's promoter Tail length will decreased because any mutation will cause a loss-of-function of these regulatory regions Not just the tail will be enlarged because increased activity of the enhancer will impact many genes

Name: ennarregion of gene X, which determines the length of the tail in mic
Uploaded: 2024-03-20T06:42:41.000Z
Channel: Bartleby
Description: ennarregion of gene X, which determines the length of the tail in mice, is mutated sothat transcription factors bind it at a much higher affinity compared to the wild-type sequence.What is the most likely phenotypic outcome?Tail length will not chan

Human Heredity: Principles and Issues (MindTap Course List)

11th Edition

ISBN:9781305251052

Author:Michael Cummings

Publisher:Michael Cummings

Chapter10: From Proteins To Phenotypes

Section: Chapter Questions

Problem 21QP: Transcriptional regulators are proteins that bind to promoters (the 5-flanking regions of genes) to...

See similar textbooks

Similar questions

The transcription of a gene called YFG (your favoritegene) is activated when three transcription factors (TFA,TFB, TFC) interact to recruit the co-activator CRX. TFA,TFB, TFC, and CRX and their respective binding sitesconstitute an enhanceosome located 10 kb from the transcription start site. Draw a diagram showing how youthink the enhanceosome functions to recruit RNA polymerase to the promoter of YFG.
Mutations in bacterial promoters may increase or decrease therate of gene transcription. Promoter mutations that increasetranscription are termed up-promoter mutations, and those thatdecrease transcription are termed down-promoter mutations.The sequence of the −10 site of the promoter for the lac operonis TATGTT (see Figure 14.5). Would you expect each of thefollowing mutations to be an up-promoter or down-promotermutation?A. TATGTT to TATATTB. TATGTT to TTTGTTC. TATGTT to TATGAT
iestiðn Pre-initiation complex (PIC) is formed right before the initiation of genes, which of the following steps seemes to NOT help for the PIC formation? O TBP protein to recognize TATA box at promoter region O TFIIA to recognize the TAFS in TFIID O Enhancers to attract coactivators and activators O Silencers to attract repressor and corepressors
Lack of phosporylation of the C-terminal domian of Pol Il will result in which of the following? O Assembly of the full set of general transcription factors plus Pol II at the promoter, but unphosphorylated Pol II cannot leave the promoter region No assembly of the general transcription factors at a promoter No binding of Pol II at a promoter The unphosphorylated Pol II can initiate and elongate but cannot terminate
Please describe the regulatory role of enhancers that binds to responsible regulators to activate the target gene at a given time and place through comparing different organisms according to the presence of regulatory sequences. regulatory promoter sequence bacteria FIGURE 19-1 The regulatory ele- ments of bacterial, yeast, and human genes. Illustrated is the increasing complex- ity of regulatory sequences from a simple bacterial gene controlled by a repressor to a human gene controlled by multiple activa- tors and repressors. In each case, a promoter is shown at the site where transcription is initiated. Although this is accurate for the bacterial case, in the eukaryotic examples, transcription initiates somewhat down- stream from where the transcription ma- chine binds (see Chapter 13). Some groups of regulatory binding sites in the human reg- ulatory sequences represent enhancers, as shown in one case. yeast human enhancer
A cloned gene fragment contains a regulatory element that isrecognized by a regulatory transcription factor. Previousexperiments have shown that the presence of a hormone resultsin transcriptional activation by this transcription factor. To studythis effect, you conduct an electrophoretic mobility shift assayand obtain the following results: Explain the action of the hormone.
RNAP can access the lacz promoter irrespective of whether CAP-CAMP is binding the CAP O True O False
Wilms tumor 1, or nephroblastoma, is caused by mutations in the WT1 gene, which encodes a transcription factor. You have identified a novel variant in WT1: Arg422Pro. You have control cells and cells that have been engineered to carry the homozygous WT1 p.Arg422Pro mutation. You want to assess effects of this mutation on a variety of endpoints. For each endpoint listed below, choose the one technique is best suited to answer the question. Choose from: array CGH, qRT-PCR, qPCR, RNA-seq, FISH, in situ hybridization, western blot, immunostaining, WT1 ChIP-seq, WT1 ChIP-PCR, ATAC-seq, 3C Endpoint Technique? WT1 protein amount (quantitative) Western blot WT1 protein binding to all enhancers, genome-wide Chip-seq WT1 mRNA amount (quantitative) WT1 protein subcellular localization Quantitative assessment of all mRNAs in these cells (genome-wide) RNAseq Chromatin interactions between a specific WT1 chromatin binding site (identified above)…
Name the lambda promoters whose expression is regulated by the cro protein. For each promoter you named, is cro an activator or a repressor of transcription from that promoter?
The yeast gene SER3, whose product has a role in serine biosynthesis, is repressed during growth in nutrient-rich medium, so little transcription takes place, and little SER3 enzyme is produced, under these conditions. In an investigation of the repression of the SER3 gene, a region of DNA upstream of SER3 was found to be heavily transcribed when SER3 is repressed ). Within this upstream region is a promoter that stimulates the transcription of an RNA molecule called SRG1 RNA (for SER3 regulatory gene 1). This RNA molecule has none of the sequences necessary for translation. Mutations in the promoter for SRG1 result in the disappearance of SRG1 RNA, and these mutations remove the repression of SER3. When RNA polymerase binds to the SRG1 promoter, the polymerase travels downstream, transcribing the SGR1 RNA, and passes through and transcribes the promoter for SER3. This activity leads to the repression of SER3. Propose a possible explanation for how the transcription of SGR1 might…
Based on its sequence similarity to Apobec1,which deaminates Cs to Us in RNA, activation-induceddeaminase (AID) was originally proposed to work on RNA.But definitive experiments in E. coli demonstrated thatAID deaminates Cs to Us in DNA. The authors of the paperexpressed AID in bacteria and followed mutations in aselectable gene. They found that AID expression increasedmutations about fivefold above the background level inthe absence of AID expression. More importantly, theyfound that 80% of the induced mutations were G→A orC→T. Does this fit with your expectation if AID-inducedmutations arose by deamination of C to U in the DNA?
8. Yeast genes have cis-acting elements upstream oftheir promoters, similar to enhancers, called upstreamactivating sequences or UASs. Several target genes involved in galactose utilization are regulated by onetype of UAS called UASG, which has four bindingsites for an activator called GAL4. Two target genesregulated by UASG are GAL7 and GAL10. The GAL80 protein is an indirect repressor of GAL7 and GAL10transcription: At UASG, GAL80 binds to GAL4 protein and blocks GAL4’s activation domain. In thepresence of galactose, GAL80 no longer binds GAL4.In which gene(s) (GAL4 and/or GAL80) shouldyou be able to isolate mutations that allow the constitutive expression of the target genes GAL7 andGAL10 in the absence of galactose? In each case,what characteristics of the protein would the mutationdisrupt?